Northwestern Medicine and global startup accelerator Founders Factory have introduced the inaugural group of European artificial intelligence startups selected for their new international healthcare accelerator.
The initiative is designed to help emerging companies develop advanced technologies that can improve healthcare delivery, patient outcomes, and the future of medical systems.
The program brings together AI entrepreneurs from across the United Kingdom and Europe with one of the United States’ leading academic healthcare organizations, creating opportunities to accelerate the development and real-world adoption of innovative health technologies.
Partnership Aims to Bridge Innovation and Clinical Practice
The accelerator provides participating startups with direct access to Northwestern Medicine’s extensive clinical environment, enabling them to refine, validate, and scale their AI-powered solutions.
Through collaboration with clinicians, researchers, and healthcare professionals, founders will gain practical experience in testing and deploying technologies within a major healthcare ecosystem.
Northwestern Medicine operates one of the country’s largest integrated academic healthcare systems, comprising 11 hospitals, more than 5,400 affiliated physicians, over 200 care locations, and a strong research network centered around Northwestern Memorial Hospital in Chicago.
Startups Selected for the First Cohort
Six AI-driven healthcare companies have been chosen for the accelerator’s first intake, each addressing different areas of medicine through advanced technology.
Uncovr, founded by Ines Iraki, Johann Diep, and Professor Eric Vibert, is developing artificial intelligence tools that improve the way surgical procedures are analyzed, documented, coded, and used for medical education.
Based in Paris and New York, the company recently secured $6 million in seed funding and is building datasets that could support future autonomous surgical systems.
London-based Genie Fertility is advancing reproductive health research through an AI-powered discovery platform.
The company was co-founded by scientists from the Universities of Cambridge, Oxford, and Imperial College London and is focused on identifying molecular biomarkers that could improve fertility research and patient care.
Cancer Diagnostics and Women’s Health Among Key Priorities
Nucleo is building AI-driven infrastructure to automate oncology diagnostics, with the goal of reducing the time between cancer diagnosis and treatment from roughly 10 weeks to just 10 days.
The company is headquartered in San Francisco and is developing technology intended to streamline cancer care pathways.
Paris-based Matricis has developed a medical-grade AI copilot designed to help radiologists identify endometriosis earlier by assisting with the interpretation of pelvic MRI scans, potentially improving diagnosis for women living with the condition.
Neurotechnology and Administrative Automation Complete the Cohort
Cambridge-based Myonerv is focused on stroke rehabilitation through wearable neurotechnology that monitors and treats stroke-related paralysis.
Its solution aims to improve recovery outcomes by combining medical devices with advanced monitoring capabilities.
Another Cambridge company, Aykua, is addressing administrative challenges within U.S. healthcare.
Its digital platform automates Family and Medical Leave Act (FMLA), disability, and accommodation paperwork by managing patient requests, processing payments, and analyzing medical records, allowing clinical staff to dedicate more time to patient care.
Accelerator Seeks to Speed Adoption of AI in Healthcare
By combining the expertise of Northwestern Medicine with Founders Factory’s experience in supporting startups, the accelerator is intended to help promising AI healthcare companies move more quickly from development to clinical implementation.
Organizers hope the collaboration will accelerate innovation across multiple medical specialties while supporting technologies capable of improving efficiency, diagnosis, treatment, and overall patient care.
